Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Guardant ...

Just days after Lydia Dutcher gave birth to her son Theo, she learned she had a tumor in her placenta and was diagnosed with ...

“At our corporate R&D event, we reported positive updated interim data from our ongoing ACR-368 Phase 2b study in endometrial cancer patients with large tumors and aggressive histopathologies ...

Faeth Therapeutics, a clinical-stage biotechnology company integrating precision nutrition with combination therapies to ...

WELLINGTON, Colo. — A tight-knit northern Colorado town is stepping up to support one of its own as the owner of a local ...

In arm 1 of the trial, the dose-escalation portion, patients will receive mRNA-4106 at a test dose as monotherapy. In arm 2, ...

A landmark review, now published in the Journal of Experimental & Clinical Cancer Research, offers a sweeping and ...

Q1 2025 Earnings Call Transcript May 19, 2025 Compugen Ltd. misses on earnings expectations. Reported EPS is $-0.08 EPS, ...

Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for ...

Diane Kraus dedicated the last years of her life to advocating for medical aid in dying. Her own death was everything she ...